SGTX

Sigilon Therapeutics, Inc. SGTX

Trading inactive

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode SGTX KRON TCRR RPHM ACHL HTBX ALVR SYRE BLUE SURF
6M 51.62 % -11.13 % 48.18 % 4.60 % 48.00 % 0.00 % -44.83 % 58.66 % -42.81 % 60.95 %
YTD 400.45 % -9.29 % 48.00 % 9.64 % 29.82 % 0.00 % -5.22 % -0.08 % -42.81 % 31.24 %
1Y 166.23 % -29.60 % -48.97 % -76.67 % 89.04 % -11.52 % -43.65 % -29.50 % -73.08 % 1.90 %
3Y -95.03 % -83.27 % -90.36 % -74.62 % -42.41 % 36.00 % -91.91 % -7.46 % -95.08 % -86.09 %
5Y -95.03 % -96.75 % -90.18 % 21.33 % -91.06 % -88.11 % -98.32 % -88.07 % -99.35 % -88.22 %
10Y -95.03 % -96.75 % -90.18 % 21.33 % -91.06 % -99.64 % -98.32 % -90.24 % -99.76 % -91.97 %
From the beginning -95.03 % -96.75 % -90.18 % 21.33 % -91.06 % -99.64 % -98.32 % -90.24 % -98.57 % -91.97 %

Dividend